Cargando…
AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways
Prostate cancer (PCa) is the most common cancer in men. The androgen receptor (AR) has a pivotal role in the pathogenesis and progression of PCa. Many therapies targeting AR signaling have been developed over the years. AR signaling inhibitors (ARSIs), including androgen synthesis inhibitors and AR...
Autores principales: | Tortorella, Elisabetta, Giantulli, Sabrina, Sciarra, Alessandro, Silvestri, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917224/ https://www.ncbi.nlm.nih.gov/pubmed/36768370 http://dx.doi.org/10.3390/ijms24032046 |
Ejemplares similares
-
A Perspective of Immunotherapy for Prostate Cancer
por: Silvestri, Ida, et al.
Publicado: (2016) -
AR Signaling and the PI3K Pathway in Prostate Cancer
por: Crumbaker, Megan, et al.
Publicado: (2017) -
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
por: Shorning, Boris Y., et al.
Publicado: (2020) -
Effect of 1-MHz ultrasound on the proinflammatory interleukin-6 secretion in human keratinocytes
por: Giantulli, Sabrina, et al.
Publicado: (2021) -
Association of polymorphisms of PTEN,
AKT1, PI3K, AR, and
AMACR genes in patients with prostate
cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)